Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Organization / System Development
Government (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Clinical study phase I